A Study of MK-2060 in Healthy Participants (MK-2060-016)

NCT06582602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis

Interventions

BIOLOGICAL: MK-2060
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC